Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,592 public trials 2,146 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

NCT06919965

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Academic Urology and Urogynecology of Arizona Sun City, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Colorado Clinical Research Lakewood, Colorado, United States
  • Georgia Urology Atlanta, Georgia, United States
View all 112 locations
View Trial Details
Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06995677

Conditions
Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations
  • Urology Centers of Alabama Homewood, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Tri Valley Urology - Murrieta Murrieta, California, United States
  • Eisenhower Medical Associates Rancho Mirage, California, United States
View all 47 locations
View Trial Details
Recruiting

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

NCT04616560

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Female Urogenital Diseases, +25 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 29 locations
View Trial Details
Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

NCT07419841

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • START New York Lake Success, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • Prisma Health Cancer Institute Greenville, South Carolina, United States
View Trial Details
Recruiting

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT06929286

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

NCT07309445

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 16 locations
View Trial Details
Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
View all 134 locations
View Trial Details

Related conditions